The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of second primary malignancy (SPM) in patients with mucosa-associated lymphoid tissue lymphoma (MALToma).
 
Nibash Budhathoki
No Relationships to Disclose
 
Sunita Timilsina
No Relationships to Disclose
 
Charles Thomas
No Relationships to Disclose
 
Aaron Damato
No Relationships to Disclose
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Genentech/Roche; Janssen; Merck; MorphoSys; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); LAM Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Millennium (Inst); Roche/Genentech (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Marc Justin Braunstein
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Celgene; Janssen; Janssen; Karyopharm Therapeutics; Takeda; Verastem
Research Funding - Janssen (Inst); Janssen (Inst)